Teresa Frisan Selected Research

Mutagens

12/2021	Characterization of macrophage infiltration and polarization by double fluorescence immunostaining in mouse colonic mucosa.
12/2021	Detection of DNA damage by alkaline comet assay in mouse colonic mucosa.
1/2021	Bacterial genotoxins induce T cell senescence.
1/2020	Bacterial Genotoxin-Induced DNA Damage and Modulation of the Host Immune Microenvironment.
12/2019	Infection with genotoxin-producing Salmonella enterica synergises with loss of the tumour suppressor APC in promoting genomic instability via the PI3K pathway in colonic epithelial cells.
1/2019	A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis.
4/2016	The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection.
8/2015	Bacterial Genotoxins: Merging the DNA Damage Response into Infection Biology.
1/2015	Bacterial genotoxins promote inside-out integrin β1 activation, formation of focal adhesion complexes and cell spreading.
1/2013	Chronic exposure to the cytolethal distending toxins of Gram-negative bacteria promotes genomic instability and altered DNA damage response.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teresa Frisan Research Topics

Disease

10	Neoplasms (Cancer) 05/2021 - 04/2002
7	Infections 01/2021 - 02/2011
6	Typhoid Fever (Typhoid) 12/2021 - 12/2013
6	Genomic Instability 12/2019 - 05/2008
2	COVID-19 05/2021 - 05/2021
2	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 01/2017
2	Ataxia (Dyssynergia) 01/2019 - 01/2015
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2013 - 01/2010
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2010 - 02/2002
1	Virus Diseases (Viral Diseases) 05/2021
1	Breast Neoplasms (Breast Cancer) 05/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Adenocarcinoma 07/2020
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2019
1	Carcinogenesis 01/2019
1	Coinfection 01/2019
1	Inflammation (Inflammations) 12/2011
1	Nijmegen Breakage Syndrome 01/2010
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2002

Drug/Important Bio-Agent (IBA)

12	MutagensIBA 12/2021 - 08/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2008
6	cytolethal distending toxinIBA 01/2020 - 01/2010
4	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2010
3	Phosphotransferases (Kinase)IBA 01/2019 - 02/2002
2	Deubiquitinating EnzymesIBA 01/2021 - 12/2012
2	colibactinIBA 01/2020 - 12/2011
2	Bacterial ToxinsIBA 01/2010 - 05/2008
1	Antiviral Agents (Antivirals)IBA 05/2021
1	Interferon Type IIBA 05/2021
1	InterferonsIBA 05/2021
1	Biological ProductsIBA 05/2021
1	Polymethyl Methacrylate (Sol)IBA 05/2021
1	SilverIBA 05/2021
1	titanium dioxide (Titania)FDA Link 05/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	PolyketidesIBA 01/2020
1	Calcibiotic Root Canal SealerIBA 12/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017
1	IntegrinsIBA 01/2015
1	Dynamin IIBA 12/2013
1	ChromatinIBA 01/2013
1	Ubiquitin CIBA 12/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011
1	Chloroquine (Aralen)FDA LinkGeneric 02/2011
1	p38 Mitogen-Activated Protein KinasesIBA 05/2008
1	AntigensIBA 04/2002

Therapy/Procedure

1	Neoadjuvant Therapy 07/2020
1	Immunotherapy 07/2020